2m 2m 2m 2m 2m 2m 2m
Dexcom (DXCM)
NASDAQ
$78.50+$0.18 (+0.23%)
Price as of Oct 23, 2026 9:38 AM EDT- $29.6BMarket Cap
- 10.22%1-Year Change
- Medical DevicesIndustry
Dexcom (DXCM)
$78.50+$0.18 (+0.23%)
DXCM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $78.32 | ||
Change | -$1.94 (-2.42%) | ||
Open | $79.90 | ||
High | $80.49 | ||
Low | $77.11 | ||
Previous Close | $80.26 | ||
Volume | 10,794,302 | ||
30-Day Average Volume | 3,879,455 | ||
1-Week Change | -10.71% | ||
1-Month Change | -12.52% | ||
1-Year Change | 10.22% | ||
3-Year Change | -8.90% | ||
5-Year Change | -44.71% | ||
Fundamentals | |||
Shares Outstanding | 377.4M | ||
Total Assets | $6.5B | ||
Market Cap | $29.6B | ||
Enterprise Value | $29.7B | ||
Period: QTR TTM FY | |||
Revenue | $1.3B | ||
Net Income | $249.1M | ||
Free Cash Flow | $184.5M | ||
EBIT | $319.7M | ||
EBITDA | $387.9M | ||
Net Working Capital | $1.7B | ||
EPS | $0.64 | ||
Enterprise Value/EBITDA | 77 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 11 | ||
P/E | 122 | ||
PEG | 5 | ||
Price/Free Cash Flow | 160 | ||
Price/Operating Cash Flow | 110 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 4 : 1 | ||
Last Split Date | 06/13/2022 | ||
Earnings & Revenue